Funding for this research was provided by:
U.S. Department of Defense (PR130106)
Received: 12 December 2017
Accepted: 26 June 2018
First Online: 13 July 2018
: All experiment were conducted with adherence to the NIH Guide for the Care and Use of Laboratory Animals. The animal protocol was approved by the Animal Care and Use Committee of the University of Colorado.
: Dr. Johnson, Lanaspa and Sanchez-Lozada are members of Colorado Research Partners LLC that is making inhibitors of fructose metabolism. Dr. Johnson is also on the Scientific Board of Kibow, Inc. and XORT therapeutics.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.